Skip to content

Repligen RGEN Restructuring Charges

Restructuring Charges at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$31.58M+32.4%
STERIS logo
STERISSTE
$0-100%
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$6M-64.7%
Revvity logo
RevvityRVTY
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Gross profit$108.3M+18.5%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's restructuring charges?
Repligen (RGEN) reported restructuring charges of $1.5M in Q1 2026.
How has Repligen's restructuring charges changed year-over-year?
Repligen's restructuring charges decreased by 24.2% year-over-year, from $1.97M to $1.5M.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.